In AD, there is no evidence for systemic CRP upregulation in blood or CSF, but CRP mRNA levels in brain, particularly in hippocampus, an early site of AD pathology, were increased by over 20-fold versus controls [115], pointing to local inflammation in the brain. Here, CRP is linked to Alzheimer disease.